2024 NINDS IGNITE Program Funding Opportunities and Q&A скачать в хорошем качестве

2024 NINDS IGNITE Program Funding Opportunities and Q&A

The NINDS IGNITE Program is a suite of early translational funding opportunities (NOFOs). This webinar will describe the program and give some tips for applying. The target audience is anyone interested in funding for translating novel small molecule or biologic therapeutics for neurological disorders. The following NOFOs are discussed: PAR-25-225: Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) PAR-25-059: Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed) PAR-25-060: Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed) For more information, visit the IGNITE website: https://www.ninds.nih.gov/current-res... Speakers for this webinar include: Rebecca A. Roof, PhD: Program Director in the Division of Translational Research, NINDS Shardell Spriggs, PhD: Scientific Program Director in the Division of Translational Research, NINDS Christopher Conrad, PhD: Scientific Program Manager in the Division of Translational Research, NINDS Shruthi A. Thomas, MS: Health Program Specialist in the Division of Translational Research, NINDS For more information on this webinar, check out: https://www.ninds.nih.gov/news-events...